Dr. James Burt

James joined Pharmanovia in October 2021. Before joining he was the Executive Vice President EMENA at Accord Healthcare and oversaw branded and generic pharmaceutical activities across 65 markets.

Prior to this, he served as Vice President Hospital Business at Actavis, where he was responsible for the strategic direction of secondary-care activities worldwide. 

He holds a PhD in Chemical Engineering from the University of Birmingham, with a particular focus on biopharmaceutical manufacturing.

James is Vice-Chair of the Medicines for Europe, Value Added Medicines Sector Group.